Jeetinder Singh Mahal serves as Executive at Jasper Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jeetinder Singh Mahal has executed 12 insider transactions totaling $79.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 6, 2026 involved receiving (via award) 500,000 shares valued at $0.
Jeetinder Singh Mahal currently holds 500,000 shares of Jasper Therapeutics, Inc. (JSPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeetinder Singh Mahal has been a net seller of JSPR stock. They have purchased $0 and sold $79.6K worth of shares.
Jeetinder Singh Mahal's most recent insider trade was on Feb 6, 2026, when they sold 500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.10 |
| Planned |
| Sep 12, 2024 | JSPR | $19.1K | Sale | 900 | $21.23 | Planned |
| Jun 12, 2024 | JSPR | $6.4K | Option Exercise | 900 | $7.10 | Planned |
| Jun 12, 2024 | JSPR | $21.7K | Sale | 900 | $24.16 | Planned |
| Mar 12, 2024 | JSPR | $6.4K | Option Exercise | 900 | $7.10 | Discretionary |
| Mar 12, 2024 | JSPR | $23.8K | Sale | 900 | $26.44 | Discretionary |
| Oct 12, 2023 | JSPR | $31.6K | Payment | 37,126 | $0.85 | Discretionary |
| Jun 13, 2023 | JSPR | $6.4K | Option Exercise | 9,000 | $0.71 | Planned |
| Jun 13, 2023 | JSPR | $14.9K | Sale | 9,000 | $1.66 | Planned |
| Apr 12, 2023 | JSPR | $54.2K | Payment | 37,126 | $1.46 | Discretionary |
| Oct 12, 2022 | JSPR | $0 | Award | 214,722 | $N/A | Discretionary |